709 Trial in progress: product characteristics and clinical trial design for T-Plex, a multiplexed, enhanced T cell receptor-engineered T cell therapy for solid tumors

Benzer Materyaller

• 709 Trial in progress: product characteristics and clinical trial design for T-Plex, a multiplexed, enhanced T cell receptor-engineered T cell therapy for solid tumors
  Yazar:: Yun Wang, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-11-01)
• 364 Non-clinical development of T-Plex component TSC-200-A0201: a natural HPV16 E7-specific TCR-T cell therapy for the treatment of HPV16-positive solid tumors
  Yazar:: Kenneth Olivier, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-11-01)
• 376 Overcoming tumor heterogeneity – Clinical trial assays to prospectively assign patients customized multiplexed TCR-T cell therapy in Phase 1
  Yazar:: Yun Wang, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-11-01)
• 357 Discovery of a novel MAGEC2 epitope for TCR-T adoptive cell therapy from expanded T cell clones of TIL therapy products
  Yazar:: Qikai Xu, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-11-01)
• 156 Discovery of TSC-100: A natural HA-1-specific TCR to treat leukemia following hematopoietic stem cell transplant therapy
  Yazar:: Kenneth Olivier, ve diğerleri
  Baskı/Yayın Bilgisi: (2020-11-01)